ECO Animal Health Group Share Price

AIM:EAHUK£50.1mPharmaceuticals & Biotech

EAH Share Price Performance

EAH Community Fair Values

View all narratives

Recent EAH News & Updates

No updates

ECO Animal Health Group plc Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

n/a

Earnings per share (EPS): 0.025
Gross Margin: 45.12%
Net Profit Margin: 2.12%
Debt/Equity Ratio: 0%

View full report ›

ECO Animal Health Group plc Competitors

View more competitors

About EAH

Founded: 1972
Employees: 224
CEO: David Hallas
WebsiteView website: ecoanimalhealth.com

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, lices, and mange in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle. ECO Animal Health Group plc was founded in 1972 and is based in London, the United Kingdom.

U.K. Market Performance

7 Days: -0.2%
3 Months: 8.1%
1 Year: 5.8%
Year to Date: 6.8%

The market has stayed flat over the 7 days. More promisingly, the market is up 5.8% over the past year. As for the next few years, earnings are expected to grow by 14% per annum. Market details ›

🇪🇺 🇬🇧 Momentum Is Returning to European and UK Markets

Richard Bowman

July 2025

The tide is turning for UK & European markets. Index ETFs won’t cut it since sector spreads are massive. Picking the right companies matters now more than ever.

Last Week